DOGS · Condition guide
Canine osteosarcoma: real veterinary cases
Osteosarcoma is an aggressive bone cancer that most commonly affects large and giant-breed dogs, typically over 7 years of age. The classic presentation is persistent, often severe lameness in a forelimb (wrist or shoulder) without a clear trauma history. The tumour destroys bone from the inside out and is painful long before it's obvious on the outside.
Outcomes have improved meaningfully over the last two decades. Amputation alone resolves the pain but median survival is short; amputation plus chemotherapy (typically carboplatin) extends median survival to around 10-12 months. Limb-sparing surgery and stereotactic radiation are options in some referral centres. The earlier the diagnosis, the more options are on the table.
What vets typically check for
- Radiographs of the painful site — classic findings: cortical lysis, sunburst periosteal reaction.
- Chest radiographs (3 views) or ideally CT to stage for pulmonary metastasis.
- Bloodwork including alkaline phosphatase (elevated ALP is a poor prognostic indicator).
- Bone aspirate or biopsy to confirm diagnosis when imaging is ambiguous.
- Treatment: amputation + carboplatin (or doxorubicin) is the most common protocol.
Not a replacement for veterinary care. Use this to walk into the conversation prepared, not to self-diagnose.
Real cases from the veterinary literature
Peer-reviewed reports our semantic search surfaces for Osteosarcoma. Click into any case for the full abstract — or run a personalised search with your pet's exact details.
- Prognostic Impact of CD206+ M2-Like Macrophages in Canine Appendicular Osteosarcoma.
Veterinary and comparative oncology · 2026 · France
A group of 84 dogs diagnosed with bone cancer (osteosarcoma) were studied to see how certain immune cells (M2-like macrophages) affected their survival after treatment. The findings showed that dogs with higher levels of these immune cells had a longer overall survival time, especially when they received surgery and chemotherapy. Additionally, lighter body weight and being fema
- Tolerability and Adverse Event Profile of Fixed Dose Rate Gemcitabine in Dogs With Neoplasia.
Veterinary and comparative oncology · 2026 · United States
A group of 39 dogs with tumors received a new treatment called fixed dose rate gemcitabine, which is given slowly over two hours. While some dogs experienced side effects like low white blood cell counts and gastrointestinal issues, these were mostly mild. About 23% of the dogs showed improvement in their condition, particularly those with squamous cell carcinoma, where 63% had
- Magnetic resonance imaging features of primary appendicular bone sarcomas in 20 dogs.
The Journal of small animal practice · 2026 · France
A group of 20 dogs with confirmed bone tumors, specifically primary appendicular bone sarcomas, underwent MRI scans to help understand their condition better. Most of these dogs had osteosarcoma, a type of bone cancer, and the MRI showed various features like abnormal signals and bone damage. The imaging results were particularly useful for staging the tumors, as certain MRI se
- Prevalence and Risk Factors for Survival in Dogs and Cats With Cancer Admitted to the ICU.
Journal of veterinary emergency and critical care (San Antonio, Tex. : 2001) · 2026 · United Kingdom
A group of 114 dogs and 38 cats with cancer were admitted to the ICU, often due to breathing problems or heart issues. The study found that about 57% of these pets survived their hospital stay, but only 31% were still alive three months later. Pets that received surgery or chemotherapy had a better chance of survival compared to those who did not. Unfortunately, most of the pet
- Epidemiology of Four Major Canine Tumours in the UK: Insights From a National Pathology Registry With Comparative Oncology Perspectives.
Veterinary and comparative oncology · 2026 · Spain
A study found that certain breeds of dogs are more likely to develop specific types of cancer, including mast cell tumors, osteosarcoma, melanoma, and hemangiosarcoma. For example, Bulldog-related breeds and Retrievers have a higher risk for mast cell tumors, while Rottweilers and Shar Peis are more prone to melanoma. Neutered dogs, especially females, showed higher odds of dev
- Differential expression of miRNAs in primary canine appendicular osteosarcoma tissue and pulmonary metastases.
Veterinary pathology · 2026 · Canada
A dog with a bone cancer called osteosarcoma (OSA) often faces a tough battle, especially when it spreads to the lungs. Unfortunately, many dogs don’t survive long after diagnosis, even with treatments like amputation and chemotherapy. Researchers found that certain small molecules called microRNAs (miRNAs) are present in both the primary tumor and the lung metastases, but not
Frequently asked questions
- How fast does osteosarcoma spread?
- Micrometastasis is usually present at diagnosis even when chest x-rays look clean. That's why chemotherapy after amputation more than doubles median survival — it targets the micrometastatic disease.
- Can older dogs tolerate amputation?
- Almost always yes. The pain of osteosarcoma is severe; most dogs are much more comfortable in the first week after amputation than they were before. Excellent quality of life on three legs is the rule, not the exception.
- Are there alternatives to amputation?
- Limb-sparing surgery and stereotactic radiation therapy (SRT) are options in selected cases, often at university or large referral centres. Both can give good pain control while preserving the limb. Palliative bisphosphonates (e.g. zoledronate) plus pain control is another option for owners who decline surgery.